• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远程和无人监督的数字记忆评估可以可靠地检测阿尔茨海默病患者的认知障碍。

Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease.

机构信息

Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

German Center for Neurodegenerative Diseases, Magdeburg, Germany.

出版信息

Alzheimers Dement. 2024 Jul;20(7):4775-4791. doi: 10.1002/alz.13919. Epub 2024 Jun 12.

DOI:10.1002/alz.13919
PMID:38867417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11247711/
Abstract

INTRODUCTION

Remote unsupervised cognitive assessments have the potential to complement and facilitate cognitive assessment in clinical and research settings.

METHODS

Here, we evaluate the usability, validity, and reliability of unsupervised remote memory assessments via mobile devices in individuals without dementia from the Swedish BioFINDER-2 study and explore their prognostic utility regarding future cognitive decline.

RESULTS

Usability was rated positively; remote memory assessments showed good construct validity with traditional neuropsychological assessments and were significantly associated with tau-positron emission tomography and downstream magnetic resonance imaging measures. Memory performance at baseline was associated with future cognitive decline and prediction of future cognitive decline was further improved by combining remote digital memory assessments with plasma p-tau217. Finally, retest reliability was moderate for a single assessment and good for an aggregate of two sessions.

DISCUSSION

Our results demonstrate that unsupervised digital memory assessments might be used for diagnosis and prognosis in Alzheimer's disease, potentially in combination with plasma biomarkers.

HIGHLIGHTS

Remote and unsupervised digital memory assessments are feasible in older adults and individuals in early stages of Alzheimer's disease. Digital memory assessments are associated with neuropsychological in-clinic assessments, tau-positron emission tomography and magnetic resonance imaging measures. Combination of digital memory assessments with plasma p-tau217 holds promise for prognosis of future cognitive decline. Future validation in further independent, larger, and more diverse cohorts is needed to inform clinical implementation.

摘要

简介

远程无监督认知评估有可能补充和促进临床和研究环境中的认知评估。

方法

在这里,我们评估了无监督远程记忆评估在无痴呆症的瑞典 BioFINDER-2 研究个体中的可用性、有效性和可靠性,并探讨了它们在未来认知下降方面的预后效用。

结果

可用性评价良好;远程记忆评估与传统神经心理学评估具有良好的结构效度,并且与 tau 正电子发射断层扫描和下游磁共振成像测量显著相关。基线时的记忆表现与未来的认知下降有关,并且通过将远程数字记忆评估与血浆 p-tau217 相结合,可以进一步提高对未来认知下降的预测。最后,单次评估的重测信度为中等,两次评估的总重测信度为良好。

讨论

我们的结果表明,无监督的数字记忆评估可能可用于阿尔茨海默病的诊断和预后,可能与血浆生物标志物相结合。

要点

远程和无监督的数字记忆评估在老年人和阿尔茨海默病早期个体中是可行的。数字记忆评估与临床神经心理学评估、tau 正电子发射断层扫描和磁共振成像测量相关。数字记忆评估与血浆 p-tau217 的结合有望预测未来认知下降的预后。需要进一步在独立的、更大的、更多样化的队列中进行验证,以告知临床实施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/7c180a0e3002/ALZ-20-4775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/2504902b893c/ALZ-20-4775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/ac5a9943fe64/ALZ-20-4775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/c004e14a7e33/ALZ-20-4775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/bf96e729f8b9/ALZ-20-4775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/7c180a0e3002/ALZ-20-4775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/2504902b893c/ALZ-20-4775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/ac5a9943fe64/ALZ-20-4775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/c004e14a7e33/ALZ-20-4775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/bf96e729f8b9/ALZ-20-4775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de4/11247711/7c180a0e3002/ALZ-20-4775-g001.jpg

相似文献

1
Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease.远程和无人监督的数字记忆评估可以可靠地检测阿尔茨海默病患者的认知障碍。
Alzheimers Dement. 2024 Jul;20(7):4775-4791. doi: 10.1002/alz.13919. Epub 2024 Jun 12.
2
Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease.基于智能手机的非监督高频认知评估在有阿尔茨海默病风险的老年人中是可靠、有效且可行的。
J Int Neuropsychol Soc. 2023 Jun;29(5):459-471. doi: 10.1017/S135561772200042X. Epub 2022 Sep 5.
3
Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer's spectrum.数字认知评估作为预测阿尔茨海默病谱系中未来认知能力下降和 tau 积累的低负担标志物。
Alzheimers Dement. 2024 Oct;20(10):6881-6895. doi: 10.1002/alz.14154. Epub 2024 Sep 6.
4
Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly.联合检测血浆 Aβ和 p-tau217 可提高对非痴呆老年人脑淀粉样蛋白的检测效果。
Alzheimers Res Ther. 2024 May 23;16(1):115. doi: 10.1186/s13195-024-01469-w.
5
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.利用血浆磷酸化tau 蛋白联合其他可及的检测手段预测未来的阿尔茨海默病痴呆。
Nat Med. 2021 Jun;27(6):1034-1042. doi: 10.1038/s41591-021-01348-z. Epub 2021 May 24.
6
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.血液磷酸化 tau 181 作为阿尔茨海默病的生物标志物:使用来自四个前瞻性队列的数据进行的诊断性能和预测模型研究。
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
7
A remote digital memory composite to detect cognitive impairment in memory clinic samples in unsupervised settings using mobile devices.一种远程数字记忆合成工具,用于在无监督环境下使用移动设备检测记忆门诊样本中的认知障碍。
NPJ Digit Med. 2024 Mar 26;7(1):79. doi: 10.1038/s41746-024-00999-9.
8
Continuous Associations between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer's Disease.远程自我管理认知测量与阿尔茨海默病影像学生物标志物的持续关联。
J Prev Alzheimers Dis. 2024;11(5):1467-1479. doi: 10.14283/jpad.2024.99.
9
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.血浆磷酸化 Tau217 水平与早期阿尔茨海默病 Tau 正电子发射断层扫描的相关性。
JAMA Neurol. 2021 Feb 1;78(2):149-156. doi: 10.1001/jamaneurol.2020.4201.
10
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.使用血浆生物标志物预测临床前阿尔茨海默病的纵向认知下降。
JAMA Neurol. 2023 Apr 1;80(4):360-369. doi: 10.1001/jamaneurol.2022.5272.

引用本文的文献

1
Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson's disease.帕金森病轻度认知障碍早期诊断中多模态生物标志物的研究进展
Front Neurol. 2025 Aug 29;16:1652378. doi: 10.3389/fneur.2025.1652378. eCollection 2025.
2
Impacts of Environmental Distractions and Interruptions on Unsupervised Digital Cognitive Assessments in Older Adults: Cognitive Ecological Momentary Assessment Study.环境干扰和中断对老年人无监督数字认知评估的影响:认知生态瞬时评估研究
JMIR Mhealth Uhealth. 2025 Sep 8;13:e71578. doi: 10.2196/71578.
3
Practice effects on digital cognitive assessment tools: insights from the defense automated neurobehavioral assessment battery.

本文引用的文献

1
A remote digital memory composite to detect cognitive impairment in memory clinic samples in unsupervised settings using mobile devices.一种远程数字记忆合成工具,用于在无监督环境下使用移动设备检测记忆门诊样本中的认知障碍。
NPJ Digit Med. 2024 Mar 26;7(1):79. doi: 10.1038/s41746-024-00999-9.
2
Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias.用于阿尔茨海默病及相关痴呆症诊断和预后的可扩展血浆和数字认知标志物。
Alzheimers Dement. 2024 Mar;20(3):2089-2101. doi: 10.1002/alz.13686. Epub 2024 Jan 15.
3
Remote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adults.
数字认知评估工具的练习效应:来自国防自动化神经行为评估量表的见解
Alzheimers Dement. 2025 Sep;21(9):e70644. doi: 10.1002/alz.70644.
4
Executive functioning and processing speed as predictors of global cognitive decline in Alzheimer's disease.执行功能和处理速度作为阿尔茨海默病整体认知衰退的预测指标。
J Alzheimers Dis Rep. 2025 Aug 6;9:25424823251363549. doi: 10.1177/25424823251363549. eCollection 2025 Jan-Dec.
5
Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease.典型阿尔茨海默病中的tau蛋白、萎缩与特定领域认知障碍
Alzheimers Dement. 2025 Jul;21(7):e70511. doi: 10.1002/alz.70511.
6
Advancing the science of recruitment for Alzheimer's clinical trials: Challenges and opportunities.推进阿尔茨海默病临床试验招募工作的科学进展:挑战与机遇。
J Prev Alzheimers Dis. 2025 Aug;12(7):100230. doi: 10.1016/j.tjpad.2025.100230. Epub 2025 Jun 12.
7
Integrating plasma p-tau217 and digital cognitive assessments for early detection in Alzheimer's disease.整合血浆p-tau217和数字认知评估用于阿尔茨海默病的早期检测。
Alzheimers Dement. 2025 Jun;21(6):e70355. doi: 10.1002/alz.70355.
8
A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer's disease.对临床前阿尔茨海默病远程和无监督数字认知评估的范围综述。
NPJ Digit Med. 2025 May 10;8(1):266. doi: 10.1038/s41746-025-01583-5.
9
Moving toward the digitalization of neuropsychological tests: An exploratory study on usability and operator perception.迈向神经心理学测试的数字化:一项关于可用性和操作者认知的探索性研究。
Digit Health. 2025 May 5;11:20552076251334449. doi: 10.1177/20552076251334449. eCollection 2025 Jan-Dec.
10
Integrating Plasma pTau-217 and Digital Cognitive Assessments for Early Detection in Alzheimer's Disease.整合血浆pTau-217与数字认知评估用于阿尔茨海默病的早期检测
medRxiv. 2025 Mar 4:2025.03.03.25323297. doi: 10.1101/2025.03.03.25323297.
远程和门诊数字认知筛查工具在区分认知健康的老年人脑淀粉样蛋白状态方面优于蒙特利尔认知评估量表(MoCA)。
Alzheimers Dement (Amst). 2023 Nov 27;15(4):e12500. doi: 10.1002/dad2.12500. eCollection 2023 Oct-Dec.
4
Clinical effects of Lewy body pathology in cognitively impaired individuals.认知障碍个体路易体病理的临床影响。
Nat Med. 2023 Aug;29(8):1964-1970. doi: 10.1038/s41591-023-02449-7. Epub 2023 Jul 18.
5
Ecological Momentary Assessment of Cognition in Clinical and Community Samples: Reliability and Validity Study.临床和社区样本中的认知的生态瞬时评估:可靠性和有效性研究。
J Med Internet Res. 2023 Jun 2;25:e45028. doi: 10.2196/45028.
6
Blood biomarkers for Alzheimer's disease in clinical practice and trials.阿尔茨海默病的临床实践和试验中的血液生物标志物。
Nat Aging. 2023 May;3(5):506-519. doi: 10.1038/s43587-023-00403-3. Epub 2023 May 18.
7
Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials.ClinicalTrials.gov上关于数字健康技术在神经学试验中发展情况的证据。
NPJ Digit Med. 2023 Feb 10;6(1):23. doi: 10.1038/s41746-023-00767-1.
8
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.使用血浆生物标志物预测临床前阿尔茨海默病的纵向认知下降。
JAMA Neurol. 2023 Apr 1;80(4):360-369. doi: 10.1001/jamaneurol.2022.5272.
9
Unsupervised mobile app-based cognitive testing in a population-based study of older adults born 1944.在一项针对1944年出生的老年人的基于人群的研究中,基于移动应用程序的无监督认知测试。
Front Digit Health. 2022 Nov 8;4:933265. doi: 10.3389/fdgth.2022.933265. eCollection 2022.
10
Transversal functional connectivity and scene-specific processing in the human entorhinal-hippocampal circuitry.人类内嗅皮质-海马回路中的横向功能连接和场景特异性处理。
Elife. 2022 Oct 12;11:e76479. doi: 10.7554/eLife.76479.